Riethdorf, Sabine <br/><br/>
Prospective multi-centre study to validate chromogenic in situ hybridisation for the assessment of HER2 gene amplification in specimens from adjuvant and metastatic breast cancer patients.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Feb 2011 
 - 261-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Validation Study 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-010-0881-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents<br/>Breast Neoplasms--chemistry<br/>Chromogenic Compounds<br/>Female<br/>Genes, erbB-2<br/>Germany<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization--methods<br/>In Situ Hybridization, Fluorescence<br/>Middle Aged<br/>Nucleic Acid Amplification Techniques--methods<br/>Prospective Studies<br/>Trastuzumab